Edwards Lifesciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	1,368	4,175	1,402	1,522	1,503	823.4
Depreciation & Amortization	168.6	155.2	144.9	139.6	134.8	107.2
Loss (Gain) From Sale of Assets	-10.8	-3,348	-	-	-	-
Asset Writedown & Restructuring Costs	87.1	-	-	55.1	4	-
Loss (Gain) From Sale of Investments	19.4	-5.2	0.1	51.5	-36.8	-21.2
Stock-Based Compensation	150.6	162.3	139.4	126.8	109.3	92.6
Other Operating Activities	-191.1	-337.1	-264.7	-255.3	-127.6	10.1
Change in Accounts Receivable	50.5	121.2	-141.2	-84.1	-91.1	41.9
Change in Inventory	-11.5	-256.1	-289	-213.4	19	-120.6
Change in Accounts Payable	223.3	89.5	146	-21.4	195.2	-84.5
Change in Income Taxes	-687.9	-186.7	-5.8	-5.6	62	-52.9
Change in Other Net Operating Assets	-137.2	-27.2	-236.3	-96.9	-39.8	258.3
Operating Cash Flow	1,017	542.3	895.8	1,218	1,732	1,054
Operating Cash Flow Growth	26.09%	-39.46%	-26.46%	-29.67%	64.29%	-10.87%
Capital Expenditures	-212.6	-252.4	-253	-244.6	-325.8	-407
Cash Acquisitions	-298.2	-1,062	-95.2	-	-	-
Divestitures	3,927	3,927	-	-	-	-
Sale (Purchase) of Intangibles	-4.6	-30	-13.3	-20.2	-4	-0.3
Investment in Securities	-284.3	-88.2	640.3	689.8	-1,350	-74.7
Other Investing Activities	-4,219	-182.1	-105	-172.7	-42.6	-49.1
Investing Cash Flow	-1,091	2,313	173.8	252.3	-1,723	-531.1
Long-Term Debt Issued	-	-	-	-	5.2	16.2
Long-Term Debt Repaid	-	-	-	-	-7	-17
Net Debt Issued (Repaid)	-	-	-	-	-1.8	-0.8
Issuance of Common Stock	170.4	179.5	169.9	146.4	158.6	140.5
Repurchase of Common Stock	-852.9	-1,159	-879.6	-1,727	-512.8	-625.4
Other Financing Activities	-234.3	-3.1	-1.3	-3.8	-0.3	-1.2
Financing Cash Flow	-916.8	-983	-711	-1,585	-356.3	-486.9
Foreign Exchange Rate Adjustments	2.7	38.6	16.8	19.2	13.9	-20.5
Net Cash Flow	-988.6	1,911	375.4	-94.8	-332.8	15.8
Free Cash Flow	804.2	289.9	642.8	973.6	1,406	647.3
Free Cash Flow Growth	56.00%	-54.90%	-33.98%	-30.77%	117.26%	-30.29%
Free Cash Flow Margin	13.67%	5.33%	12.83%	21.81%	26.88%	14.76%
Free Cash Flow Per Share	1.37	0.48	1.05	1.56	2.23	1.02
Cash Interest Paid	19.6	19.6	19.9	19.3	20.2	19.9
Cash Income Tax Paid	1,020	1,166	444.9	466.7	182.5	197.9
Levered Free Cash Flow	524.5	1,351	589.83	776.73	1,009	373.75
Unlevered Free Cash Flow	536.88	1,363	600.83	788.73	1,020	383.63
Change in Working Capital	-562.8	-259.3	-526.3	-421.4	145.3	42.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.